KCTD7 Antikörper
Kurzübersicht für KCTD7 Antikörper (ABIN7245461)
Target
Alle KCTD7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification
-
Immunogen
- Synthetic peptide of human KCTD7
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:1000-1:5000, IHC 1:50-1:300, ELISA 1:5000-1:10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.56 mg/mL
-
Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- KCTD7 (Potassium Channel Tetramerisation Domain Containing 7 (KCTD7))
-
Andere Bezeichnung
- KCTD7
-
Hintergrund
- KCTD7 (Potassium Channel Tetramerization Domain Containing 7) is a Protein Coding gene. Diseases associated with KCTD7 include Epilepsy, Progressive Myoclonic 3, With Or Without Intracellular Inclusions and Cln14 Disease. Among its related pathways are Neuropathic Pain-Signaling in Dorsal Horn Neurons and Innate Immune System. An important paralog of this gene is KCTD14. This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.
-
Molekulargewicht
-
Observed_MW: Refer to figures
Calculated_MW: 33 kDa
-
UniProt
- Q96MP8
Target
-